September 11-13, 2022
Hero background

Breakout Session

AI and Drug Development: IP Implications for Protecting AI Discoveries

September 12, 2022 @ 3:30 PM CST

3:30 PM CT
September 12, 2022

Breakout Session

AI and Drug Development: IP Implications for Protecting AI Discoveries

View Session Speakers

As with many industries, Artificial intelligence (AI) enabled solutions are revolutionizing every stage of the drug development process to accelerate it and improve its efficiency. As biopharmaceutical companies increasingly rely on AI, there is a real possibility that a drug substance, drug product, or a drug formulation soon will be invented by AI. If and when that happens, who owns the intellectual property for those inventions?

Patent Offices around the world, including the United States Patent and Trademark Office, have determined that an AI cannot be listed as an inventor. If AI-created inventions cannot be patented, will the biopharmaceutical companies be interested in pursuing inventions using AI to develop drug products?

Our panel will tackle these and other complicated and thorny legal issues presented by the use of AI in the drug development process.

CLE Materials

Protecting Artificial Intelligence Inventions in Drug Development



Add to Calendar 07/03/2022 4:12 PM America/Chicago AI and Drug Development: IP Implications for Protecting AI Discoveries

As with many industries, Artificial intelligence (AI) enabled solutions are revolutionizing every stage of the drug development process to accelerate it and improve its efficiency. As biopharmaceutical companies increasingly rely on AI, there is a real possibility that a drug substance, drug product, or a drug formulation soon will be invented by AI. If and when that happens, who owns…

Session Speakers